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Abstract
Background: The Rheumatoid Arthritis Impact of Disease (RAID) score was developed as a European League
Against Rheumatism initiative to obtain a patient reported outcome score for clinical trials in patients with
rheumatoid arthritis (RA), based on patients’ perception of the impact of the disease on several domains of health.
The objective of this study was to assess the content validity of this score in Dutch RA patients.
Methods: During three focus group discussions (n = 23), patients with RA reflected on comprehensiveness of the
RAID to measure impact of RA on their life, relevance of the RAID domains and formulation of questions. Also, the
domains of the RAID score were compared to the comprehensive International Classification of Functioning,
Disability and Health core set for RA.
Results: Patients confirmed that RA had impact on five domains already incorporated in the RAID score: emotional
well-being, pain, performing daily activities, fatigue and coping. There was variation in interpretation of some of the
items of the RAID score, suggesting problems in comprehension. Patients indicated that the domains work,
relationships with others (such as family and friends) and spare time/hobbies were missed in the RAID and could
be added to obtain a more ‘complete’ picture of the impact of the disease.
Conclusion: The RAID score has fairly good content validity. If confirmed as important in other patient groups,
items in the above mentioned areas should be considered in a future upgrade.
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Background
Rheumatoid arthritis (RA) is a chronic inflammatory
joint disease that strongly affects quality of life [1–3].
The core set of outcome measures for RA clinical trials
includes three patient-reported outcomes (PROs): pain,
physical functioning and patient global assessment of
disease activity [4]. In addition, the Outcome Measures
in Rheumatology (OMERACT) group, an independent
initiative of international health professionals and patient
experts interested in outcome measures in rheumatol-
ogy, has recommended that fatigue should also be mea-
sured in all RA clinical trials; furthermore, sleep quality
and ability to work have both been mentioned as im-
portant outcomes and targeted for further instrument
development [5–7]. Several questionnaires now exist to
assess these PROs separately [8–10].
Recently the Rheumatoid Arthritis Impact of Disease
(RAID) score was developed as an initiative of the Euro-
pean League Against Rheumatism (EULAR) to combine
the most important PROs in one measure [11]. This
patient-centered response index for clinical trials in RA
was to replace the use of different questionnaires per
outcome without missing important information, and to
assess changes in outcome over time [12]. In 2011, the
construct validity, reliability and sensitivity to change of
the RAID score were documented in an international
study. A strong correlation was found with other disease
activity measures (e.g., patient global assessment visual
analogue scale (R = 0.76)), as well as a high reliability
(intraclass correlation coefficient: 0.90) and a good sensi-
tivity to change (standardized response mean: 0.9) [13].
As the domains of the RAID were initially identified by
a relatively small group of patient partners (n = 10), we
decided to assess the content validity of the RAID ques-
tionnaire as well as comprehensibility before implemen-
tation of the RAID score in the Netherlands.
Materials and methods
Development of the RAID score
The development of the RAID score has been described
elsewhere [12]. In brief, a priori the developers decided
to create an instrument with seven domains. In the first
phase, domains were initially elaborated through a ‘focus
group’-type meeting where 10 patients (one patient per
country, ten countries participated) identified 17 health
domains on which RA had impact, based on patients’
personal experiences. To reduce the list of domains, 100
new patients ranked these domains in order of decreas-
ing impact of RA on their lives.
In phase 2, items to measure the candidate domains
were identified. One or several items, instruments or
whole questionnaires were selected for each domain.
When no validated instruments were available, a numer-
ical rating scale was formulated by the group and
validated with the 10 patients with arthritis who partici-
pated in the first phase. In the third phase, relative
weights of the candidate domains were obtained, in
which the second part of phase 1 was repeated with 500
patients. In the last phase, the generalizability of the pre-
liminary RAID was assessed by comparing ranks of im-
portance of chosen domains across countries (using data
from phase 1), and by analyzing weights across disease
and demographic characteristics. The final RAID score
covers seven health domains: pain, problems with daily
functioning, fatigue, sleep, physical well-being, emotional
well-being and coping with RA, each represented by a
numerical rating scale ranging from 0 to 10 [12]. The
complete questionnaire and related calculation rules can
be found in Additional file 1.
The translation of the questionnaire into Dutch was
performed by the RAID developers. Two independent
researchers (with Dutch as their mother tongue) trans-
lated the questionnaire into Dutch. After reaching con-
sensus, back-translation was performed by the same two
researchers. A multidisciplinary consensus meeting was
held in which the original version and the back-
translation were compared and in the last step the final
version was pre-tested on five patients [12].
Current study: content validity
Content validity as defined by the Consensus-based
Standards for the selection of health Measurement In-
struments (COSMIN) group addresses the question: are
all items included in the RAID score an adequate reflec-
tion of the construct to be measured? Content validity is
often considered one of the most important measure-
ment properties and therefore addressed first, before
looking at other measurement properties such as con-
struct validity. Construct validity is defined as the degree
to which the scores of the RAID score are consistent
with hypotheses that were made in advance (e.g., about
relation of scores to scores of other instruments) based
on the assumption that the RAID score validly measures
the construct to be measured [14].
This study used a part of the COSMIN checklist to
evaluate the content validity of the RAID [15, 16]. This
checklist was developed to evaluate the methodological
quality of studies on measurement properties [15]. The
items in box D of the COSMIN checklist were slightly
adapted to evaluate the quality of the instrument. Evi-
dence was collected to answer the following four ques-
tions, based on box D of the COSMIN checklist, as
evidence for content validity: 1) Do all items refer to
relevant aspects of the construct to be measured? 2) Are
all items relevant for the study population? 3) Are all
items relevant for the purpose of the measurement in-
strument? And 4) do all items together comprehensively
reflect the construct to be measured?
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Focus group discussions
To gain insight into the domains of health upon
which RA impacts, patients were asked to participate
in focus group discussions (FGDs). A FGD is a form
of qualitative research that retrieves data on patients’
experiences, opinions, perspectives and assumptions
[17]. In a FGD patients are engaged to interact with
each other. In this study, patients were asked to
describe the impact of RA on their life (question 2 of
box B), and whether they felt that the RAID score
covered all items that should be measured to assess
the impact of RA on their life (question 4 of box B).
We were also interested to assess the comprehensibil-
ity of the RAID. Therefore, in the second part of the
FGD, patients were asked if they felt that the RAID
questions were understandable and clearly defined
(see Table 1 for the structure of the focus group
discussions).
Study sample focus group discussions
To gather as much diversified opinion from patients as
possible, patients with diagnosed RA (≥18 years and not
suffering from multiple co-morbidities) were recruited
through two patient associations in Amsterdam and
surroundings to participate in one of three planned
FGDs (maximum 10 patients per group). These
patient associations distributed an invitation letter to
their members.
Data collection
All questions were open-ended [18]. Table 1 shows
the FGD structure used. Data (on the domains
mentioned by the patients) were gathered until satur-
ation was reached. With data saturation, focus group
interviews were performed until no new categories,
themes or explanations emerged from the patients
[19]. Patients were informed that the FGDs were
moderated (LHvT), taped and anonymously tran-
scribed (BSB) by researchers not involved in the clin-
ical management of any of the patients. Under Dutch
law, this study does not need approval from an Eth-
ical Review Board. However, all patients gave oral in-
formed consent at the start of the group sessions on
the use of their provided responses, which was
recorded.
Data analyses
To thoroughly investigate all expressions of the patients,
the focus group moderator asked in-depth questions
such as: ‘In what way do you mean that?’ or ‘Could you
provide us with an example?’ The data were analyzed
using the interpretative phenomenological analyses
method that assesses content as well as the underlying
cognitive and emotional concepts [20, 21]. A bottom-up
approach is applied to avoid prior assumptions and
minimize bias. Two researchers experienced in qualita-
tive research (MMtW and LHvT) systematically and
independently analyzed the transcripts to identify
relevant themes, and subsequently agreed to the same
set of major themes during a consensus meeting. The
researchers also discussed whether all RAID items po-
tentially could show change when the disease improves
or deteriorates (question 3 of COSMIN box D).
World Health Organization International Classification of
Functioning, Disability and Health core set for RA
comparison
In order to answer question 1 of COSMIN box D, the
domains in the RAID score were compared to the
domains in the World Health Organization (WHO)
comprehensive core set of International Classification of
Functioning, Disability and Health (ICF) for RA to see
whether all items refer to relevant aspects of the
Table 1 Basic structure of the group focus discussions
1. Could you introduce yourself and tell us how long ago rheumatoid
arthritis (RA) was diagnosed?
2. If you think of all aspects of your life RA had influence on, what is the
first thing that pops up in your mind?
Introduction of RAID score by LHvT to the participants:
Recently, a group of people in Europe developed a questionnaire that
measures the impact of RA on the patient's life on various health topics.
Before a questionnaire can be used in daily practice or research, it must
first be examined whether the questionnaire works properly and is
reliable. That is why we are here today. The purpose of this meeting is
to investigate whether you think that this questionnaire is complete, or
if you miss domains/subjects in this questionnaire. In response to a
question I will ask you, you can discuss and debate your answer with
each other. In the meantime I will keep an eye on the equal input of
everyone. The entire meeting is recorded on tape that we will analyze
later. After about 45 minutes we will have a break of 15 minutes. The
persons who developed the list found that the questionnaire had to
remain short. Therefore there are seven topics included in this
questionnaire, as you can see on the paper version we just provided
you with. The topics include pain, problems with daily functioning,
fatigue, sleep, physical well-being, emotional well-being and handling
your disease.
3. What do you think of these topics?
4. Are these seven topics the most relevant to assess the impact of RA
on your life?
Second introduction of LHvT after the break:
In the second part of this meeting, we would like to evaluate the
questions and how they are formulated to see if everything is
understandable and clear to you.
5. Evaluation of all questions separately by asking if all questions were
clearly defined and understandable.
6. Today, I wanted to gain insight into all the domains in which RA had
impact on in your life. Have I forgotten to ask you something that
relates to this subject? Is there something you would like to say if you
did not have the opportunity during the discussions? Would you like to
add something to the previous discussions?
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construct to be measured (see Additional file 2) [22].
The ICF makes it possible to assess not only the medical
aspects of the patients’ disease, but also to take into ac-
count all aspects of their life such as participation and
environment [23]. ICF core sets, such as the ICF core set
for RA, have been developed to describe a patient’s level
of functioning specifically for one disease as only the
relevant categories for this disease are listed in the core
set [24]. Previously, several studies assessed the validity
of the ICF core set for RA. In one of these studies, pa-
tients almost entirely confirmed the domains included in
the core set in several focus group meetings [25].




Performing or maintaining a job
1 P1.5: Almost 4 years ago I got acute and complete RA manifestations in almost all of my limbs, symmetrical. Everything fell apart. I use
the normal ‘MTX misery’ and I’m greatly improved. I have a very positive look on everything. But my whole worldwide career was
over and out in one stroke.
2 P1.7: You will not be cured. You can say goodbye to that. But you can adapt to what you ARE able to do. You don’t have to look at
what you can’t do.
P1.2: That kept me at work for 20 years.
P1.7: They threw me out of my job because I visited the doctor too often.
3 P2.3: Yes, at a certain point I had to decide that I would step back from my company because I physically couldn’t handle it anymore.
But I kept at it long enough to get the business on its feet.
P2.2: And that’s pretty difficult, when you’ve started it yourself, such a business.
P2.3: You bet.
P2.2: So you’re completely out of it?
P2.3: Yes, in the end I was declared work disabled, but the company is still running and I’m the nicest volunteer there.
4 P3.4: I’ve had arthritis for the last 18 years and especially the last 5 years it has had enormous impact. It went pretty well for quite a
long time. The first year was really bad, I was on sick leave the whole year. Then, after starting with medication, actually, I started
building it up again slowly, and up to 5 years ago it was sort of stable. And now it’s so bad, especially the last half year, that
sometimes I think I’m just going to let everything drop and quit. It might not look like that today, but that’s the way it is…
P3.2: It varies from day to day.
P3.4: Yes, yes, so actually I’ve now been declared fully disabled for work.
Coping with the disease
5 P2.1: The limitations are a constant search for what your limits are, I find that very difficult. And I’m also finding out that even after all
those years, I don’t really know the balance, because I don’t know. The moment I feel up to it, I go all the way and then a few days
later you get a relapse, so that is bothersome. Walking is hard, you have pain, fatigue. So there is always a sort of constant
considerations what to do. Sometimes you get a flare if you’ve gone too far. So you’re constantly making do and I find that very hard.
6 P2.5: Sometimes it’s really weird, because then you want to pick up a pen and you can’t for some reason… your hand locks down
and you can’t get the pen into your hand. And sometimes I can suddenly have a day where my leg really hurts, but not the joints,
just the muscle, and it lasts for a day and then it is gone and I really drag my feet and stumble around for a day and the next day it is
gone.
7 P2.3: And then somebody says: are you coming sailing this weekend. And I say: yes! And then the first day goes well, and the second
day slightly less, and then you get home and the next three days you’re sort of knocked out a little. And, so, I really have to make a
positive choice. I just feel like to be out on the water, too bad. Then the week after I’m washed out, sort of. You should stop when it
is still going really well.
P2.1: And that’s strange!
P2.3: And I don’t want to…
P2.1: No, you don’t.
8 P3.2: You have to be very disciplined in the way you allocate your energy.
P3.6: Yes, yes.
P3.2: And you know that’s really a long process.
P3.5: Yes. Safeguarding your energy level, that I find the most difficult.
P3.6: Right. I’d forgotten about that. Energy is finished, you can, you want a lot, but at a certain moment you just can’t anymore.
Information on participants: P1.2 (F, 57 years); P1.5 (M, 64 years); P1.7 (F, 65 years); P2.1 (F, 41 years); P2.2 (F, 65 years); P2.3 (F, 58 years); P2.5 (F, 43 years); P3.2 (F,
57 years); P3.4 (F, 56 years); P3.5 (F, 46 years); P3.6 (F, 63 years). F female, M male, MTX methotrexate, RA rheumatoid arthritis
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Results
Focus group discussions
The two patient organizations sent the invitation letter
to all their members (approximately 600). A total of 23
patients were willing to participate in the focus groups,
but five subsequently declined, mostly for lack of time.
The remaining 18 patients were split equally among
three FGDs. Mean age was 60 years (standard deviation
17 years), median disease duration 14 years (range 2–50
years), and 89 % of patients were women. Approximately
50 % of the patients had a high educational level (>17
years) and 17 % a low level (≤12 years). Most patients




Relationships with others (partners, children and friends)
9 P1.2: You’re in a relationship in a certain way, and if that changes totally, then you can’t, well, blame either one that it doesn’t work
anymore. Hey, you lose your job, you’re suddenly sitting at home, you need help and he (patient’s partner) certainly didn’t have that
patience. I mean, before I was in the car, there was a period that I was really very stiff and my leg would still be outside and he
would step on the gas. He was already driving off! So when it was over I felt like, I don’t have to keep up the pretense. In my
marriage, especially the last year, it was very often simply overstretching too much. Because, you know, you want to keep up, be part
of it. And be appreciated in that way, so you accept the situation. I couldn’t then, but I can now.
10 P2.1: Even my partner has something …, he understands, but then again he doesn’t.
P2.4: That sounds very familiar.
P2.1: Especially in times when it’s heavy for me, he says: ‘come on, just this little thing’. But then I think: ‘right now you have to leave
me be’. And that, that’s so difficult, because if we can’t understand it ourselves, then the other can’t either.
P2.2: No, because in fact the slap on the wrist always comes too late.
P2.5: You never get a warning signal saying: now you should stop.
11 P3.2: I’ve always been a busybody who never stopped going but at a certain moment, I had a friend, and really, my best friend, she
just didn’t have a lot of energy intrinsically, and she said at one point, when I became ill, she just didn’t get it. And she said at a
certain point, well then I actually got very mad at her, she says: ‘that disease just doesn’t suit you, I don’t understand that you…’ And
then I said, ‘well, I think the disease chooses…’
P3.5: Whom does it suit then?
P3.2: …randomly selects someone. How can you say the disease doesn’t suit me? ‘Yes but you always had so much energy’. I say: ‘But
I didn’t ask for it, did I?’ Also, she’s the one of all my friends who is the least realistic in coping with my disease, she’s still surprised
when I’m not able to do something.
Performing activities in daily life and leisure time
12 P1.4: Yes, you can’t dress yourself anymore. You can’t wipe your bum anymore. You feel, in that moment, you feel a bit powerless. A
bit. Look I wasn’t working anymore, but then you really feel switched off.
P1.7: Dependent…
P1.4: Dependent. I mean, if you can’t even slice your own bread…
13 P2.5: When I’m walking somewhere… If I walk for a really long time, or if I’m on a shopping spree with the girls, then really after an
hour, then I have to sit down for a bit.
14 P3.4: I’m a big fan of the Antilles. Usually I go with friends, but this winter I’m alone because nobody can get days off. Then I think:
oh, should I be doing this? Because then I’ll be there and not able to do anything. So those are, those are actually, small things but…
P3.6: Limitations you have in your life.
P3.2: But don’t you, when you’re there, don’t you have a lot less complaints, because, I swear I really…
P3.5: Warmth
P3.2: …That really has an impact on my body.
P3.4: True, but the flight already takes you a few days to get over.
P3.2: And sitting still all that time.
P3.4: And 6 hours of time difference.
P3.6: Yes, that’s what I mean, I can’t do that. That’s really difficult, traveling is.
P3.4: Yes, so before you’ve slightly…
P3.5: Simply recovered from.
P3.4: And then the fear of, suppose I get something there? Then I think: oh, should I be doing this?
Information on participants: P1.2 (F, 57 years); P1.4 (F, 65 years); P1.7 (F, 65 years); P2.1 (F, 41 years); P2.2 (F, 65 years); P2.4 (F, 79 years); P2.5 (F, 43 years); P3.2 (F,
57 years); P3.4 (F, 56 years); P3.5 (F, 46 years); P3.6 (F, 63 years). F female, M male
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were either married or living together (83 %). Regarding
work status, 28 % performed paid work (17 % worked
≥32 hours per week), 28 % were retired and 39 % were
fully work disabled. The results of the interviews are
presented using summaries and quotes. During the third
focus group interview, no new categories, themes or ex-
planations emerged from the patients (data saturation).
Therefore, no new patients had to be recruited.
Performing or maintaining their job was one of the
first things patients mentioned in all three FGDs. Most
patients lost their job due to their disease. This made pa-
tients uncertain about their financial situation and it af-
fected their self-confidence, both leading to feelings of
stress and increasing their perceived disease activity. Pa-
tients who were still working noticed that pain and fa-
tigue decreased their work productivity. Quotes 1–4 in
Table 2 concern this topic.
A second major issue for patients was the difficulty in
coping with their disease. RA can fluctuate with regard
to disease activity during the day, making it possible to
perform an activity at one point in time but impossible
at the next. They also mentioned they experienced diffi-
culties with coping and had to make other choices due to
their disease. Patients indicated that this was because it
felt as if their body would ‘abandon’ them while perform-
ing an activity. Quotes 5–8 in Table 2 concern this topic.
The third domain that patients discussed was the in-
fluence of their disease on relationships with others,
such as partners, children, and friends. Patients experi-
enced a lack of understanding and consideration on days
that their disease was very active; this was attributed to
the relatively ‘invisible’ nature of RA as a disease as, for
example, compared to a broken leg. Due to the disease,
the distribution of roles changed. For example, partners
would have to perform more household tasks than they
had to do before their partner was diagnosed with RA;
or patients were not able to engage in activities with
friends as they used to. Therefore, irritations, tension
and stress could occur in the relationship with others,
sometimes leading to losing a partner or friend. Quotes
9–11 in Table 3 concern this topic.
A fourth domain that was influenced by RA was per-
forming activities in daily life and in spare time. Regard-
ing routine daily activities, patients reported having
difficulty getting dressed, taking care of their children,
cooking, going to the toilet and performing household
activities. Regarding leisure-time activities, patients men-
tioned that it became difficult to perform their sports, to
go on vacation, or perform a hobby such as painting.
Quotes 12–14 in Table 3 concern this topic.
Three other domains that patients mentioned that im-
pacts their life were having pain, being fatigued and be-
ing emotional. Having pain and being fatigued restricts
functioning in all aspects of life, but having the disease
also results in emotional fluctuations. For example, pa-
tients experience anger towards their disease as it some-
times limits their functioning. Or they have the urge to
cry due to pain, or get frustrated due to the inability to
perform a task they were able to perform the day before.
Quotes 15–20 in Table 4 concern this topic.
From the seven domains in the RAID score, five were
indicated as being relevant for the study population: a)
coping with the disease; b) functional disability assess-
ment (activities performed in daily life); c) pain; d) fa-
tigue, and e) emotional well-being. The domains sleep
and physical well-being were briefly or not at all men-
tioned in the FGDs. The domains work, relationships
with third parties and leisure time activities are consid-
ered important and are missed in the RAID score by the
patients.
During their consensus meeting, the two researchers
discussed whether the RAID score can be used as an
evaluative instrument, i.e., to assess change over time-for
example, the effect of drugs on the impact of the disease
[12]. They considered all items potentially changeable,
and therefore the whole RAID score was considered
relevant for an evaluative purpose.





15 P1.3: That there are things you can’t do, well, you can
solve that in another way. But the pain I think is the worst.
P1.4: It’s so tiring, isn’t it?
P1.6: Yes terrible.
Fatigue
16 P3.5: The problem is simply that I feel very insecure about
fatigue. The fatigue that, that I…
P3.6: Fatigue, yes, that’s right.
P3.5: … notice all the time, I find it very bothersome to
function around noon, when I’ve worked I simply have
to sleep for an hour.
Emotions
17 P1.1: The first thing that popped up when I was asked to
participate in these interviews was a kind of old rage
from 15 years ago that it happened to me.
18 P1.2: This last period so many things are happening one
after the other, eh, because of this medication, all kinds
of side effects, that I’m really angry and also a bit desperate.
19 P2.3: There was a moment I had the feeling of why does
this have to happen to me?
20 P2.5: I notice that at times when I’m really tired, I can be
really grumpy with those around me.
Information on participants: P1.1 (F, 65 years); P1.2 (F, 57 years); P1.3 (F, 48
years); P1.4 (F, 65 years); P1.6 (F, 72 years); P2.3 (F, 58 years); P2.5 (F, 43 years);
P3.5 (F, 46 years); P3.6 (F, 63 years). F female, M male
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Comprehensibility
In general, the numerical rating scales may cause diffi-
culties in interpretation. In the Netherlands such ques-
tions are often answered by comparing them with school
grades (a grade 10 is outstanding and grade 1 is very
poor; however, in practice only the grades 4–9 are used).
In other words, the full range of the scale may not be
used, and patients need to reverse the anchors, as low
rather than high scores in the scales reflect the preferred
condition, which was perceived as counterintuitive.
Although the patients found the questions on daily
physical functioning, fatigue, sleep and emotional well-
being clearly defined, they also mentioned that it was
difficult to confidently ascribe fatigue or sleeping prob-
lems to RA, as these are also influenced by other
circumstances. The questions about daily physical func-
tioning and emotional well-being were interpreted by
the patients as having problems with performing house-
hold activities, and coping with their disease in the past
week, respectively. It might be more clear when concrete
descriptions of activities are provided instead of broad
concepts, e.g., by referring to hobbies and work instead
of referring to daily physical functioning.
Patients indicated that the questions on pain, physical
well-being and coping with RA were difficult to under-
stand, and not clearly formulated. Patients described
pain to be dependent on the type of activities that are
performed, and influenced by different (environmental)
circumstances. Therefore, pain perception can change
every hour making it difficult to give an average rating
over 1 week. They stated that time frames other than 1
week (for example 1 day) might be more appropriate to
use. Concerning the question on coping, patients indi-
cated they felt this question covered the same domain as
the question on emotional well-being. They were unclear
whether the subject of this question concerns coping
with RA emotionally, in daily functioning or in general.
For coping, a time period of 3 months was found to be
more appropriate than 1 week.
Concerning the question on physical well-being, it
seems that translation errors have occurred. For ex-
ample, in the Dutch version a sentence has been added
to the question on physical well-being: ‘considering your
physical well-being (apart from pain, inflammation and
fatigue)’, which is not mentioned in the English version
(see Additional file 1). Patients indicated that it is impos-
sible to set aside the pain, inflammation and tiredness in
answering this question, as these items influence the
functioning of their body and therefore their physical
well-being.
WHO ICF core set for RA comparison
The WHO ICF core set for RA comprises 96 categories,
divided over the components ‘Body structures’, ‘Body
functions’, ‘Activities and participation’, and ‘Environmen-
tal factors’ (see Additional file 2) [22]. Table 5 shows the
results of the comparison of the components of the ICF
core set and the domains as measured in the RAID
score. Most of the domains are formulated as broad con-
cepts and cover several items of the ICF core set. Fatigue
and coping are not mentioned in the ICF core set. These
could be linked to third level categories ‘b1300 Energy
level’ and ‘b4552 fatigability’ of the entire WHO ICF
framework, but fatigue is not specifically and explicitly
mentioned in the core set [24–27]. The component ‘En-
vironmental factors’ of the core set are not covered in
the RAID score, as well as the levels d660–d920 of the
component ‘Activities and participation’. Concerning
pain the ICF core set contains far more specified pain
categories, at the third level specified per body part,
which are not addressed by the RAID. Finally, all com-
ponents of ‘Body structures’ (e.g., structure of lower or
upper extremity) and ‘Body functions’ (e.g., mobility of
joint functions, sensations related to muscles and move-
ment functions) are also not covered in the RAID. How-
ever, such items are not expected to be measured in a
PRO measure.
In conclusion, five out of the seven items from the
RAID score refer to three domains of the WHO ICF
core set. RAID adds two domains not covered by the
WHO ICF, and omits four, of which two are outside the
scope of a PRO measure.
Discussion
Taking into account the impact of RA disease activity on
the daily life of patients (the aim of the RAID score) is
of high importance to rheumatology clinical practice.
Our study confirms the importance of five domains of
the RAID (coping with the disease; functional disability
assessment (activities performed in daily life); pain; fa-
tigue, and emotional well-being). Our patients also noted
Table 5 Comparison of the RAID score with the WHO ICF core
set for RA
WHO ICF core set for RA RAID score




Body structures Physical well-being
Activities and participation Functional disability assessment
Environmental factors Coping
Fatigue
ICF International Classification of Functioning, Disability and Health, RA
rheumatoid arthritis, RAID Rheumatoid Arthritis Impact of Disease, WHO World
Health Organization
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the omission of questions on (paid) work, relationships
with others, and activities performed in spare time.
In the comparison with the ICF core set, all categories
of the components ‘Body functions’ and ‘Body structures’
were covered in the domains sleep, physical well-being,
pain and emotional well-being. Approximately 75 % of
the categories in the component ‘Activities and participa-
tion’ and none of the categories in the component ‘En-
vironmental factors’ were covered by the RAID score.
On the other hand, the domains fatigue and coping
which are known to be of high importance to RA pa-
tients are not incorporated in the ICF core set for RA,
pointing to content validity problems with the ICF core
set [7, 27].
Patients also pointed out some issues with comprehen-
sion. This might partly be explained by translation er-
rors, but also due to different interpretation of the
numerical rating scales, the large time scale of 3 months
to refer to, and that the questions do not provide exam-
ples to think about. The Dutch version of the RAID
needs to be modified to reflect the English version, and
during the development of this paper we learned this
has indeed been done in 2015 (see online: http://
www.eular.org/tools_products_.cfm).
The strength of our study lies in the three FGDs per-
formed with RA patients, as this method is an effective
way to discover people’s ideas, feelings and needs about
a subject, in this case the impact of RA on several do-
mains of their life [17]. Another advantage of FGDs is
that they present a more usual setting in comparison to
individual interviews as patients are influenced by and
influencing others, just as in daily life, providing the op-
portunity for discussion and consensus [17]. Our pa-
tients were not provided with literature or the RAID
score in advance, so they had no prior knowledge on this
subject. The ten patients who participated in the original
development of the RAID score are all OMERACT pa-
tient research partners. These patients have more know-
ledge on research than average patients. Although 50 %
of our patients were also highly educated, the rest had
moderate or low educational levels. Therefore we think
our population, albeit small, better represents the entire
RA population. We did find it striking to see that the
domains sleep and physical well-being were briefly or
not at all mentioned by the patients participating in our
study, in comparison to the patient research partners
from OMERACT who are all also patients who did men-
tion these items. We do not have an explanation for this
difference in outcome.
A limitation of this study concerns the recruitment of
patients which could have biased the results. As patient
organizations distributed the invitation letter, we do not
know the exact number of invited patients. It is likely
that patients who have noticed that their disease altered
their life situation were more likely to participate in the
FGDs compared to patients who did not notice a major
impact of RA on their lives. Also our patients all had
established RA, perhaps limiting generalizability. We did
not retrieve data of other comorbidities that patients
might have. Other comorbidities might also have impact
on a patient’s life. Secondly, the transcript analysts were
familiar with the domains of the RAID score. Therefore
possible bias towards these domains might have oc-
curred. However, as saturation was reached after the
third FGD and patients were only asked about their own
experiences, we think this potential bias has a minimum
impact. Finally, the domains noted by Dutch patients
might be weighed differently by patients in other
countries.
Without question, the RAID is a major advance in the
assessment of impact of RA disease activity on everyday
life, and is useful in its current form. But at its presenta-
tion, we noted that some of the domains assessed by the
RAID are already in the RA core set, and cautioned
against double counting [28]. In this study we suggest
other domains that might be added to enhance content
validity from the patient perspective. Several studies
have pointed out that domains such as (paid) work, rela-
tionships with others, and activities performed in spare
time are important and have impact on a patient’s ‘iden-
tity’ and quality of life [5–7, 28, 29]. A future upgrade of
the tool should take these findings into consideration.
Conclusion
In conclusion, the Dutch version of the RAID score has
fairly good content validity. More research is needed to
confirm whether the domains (paid) work, relationships
with others and activities performed in spare time are
important in other patient groups. If so, these should be
considered in a future upgrade.
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